Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HealthyFood Trial
2023-506205-18-00Phase 2Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Nov 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in Antimicrobial-resistant Escherichia coli infection comparing Low-dose ciprofloxacin with Placebo (2 arms). Started Nov 2023; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Antimicrobial-resistant Escherichia coli infection
Beyond the preview
Go deeper on 2023-506205-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506205-18-00.